Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Beka Solomon"'
Publikováno v:
Journal of Alzheimer's disease : JAD. 78(2)
Background: Alzheimer’s disease (AD), the prevalent dementia in the elderly, involves many related and interdependent pathologies that manifest simultaneously, leading to cognitive impairment and death. Amyloid-β (Aβ) accumulation in the brain tr
Publikováno v:
Neural Regeneration Research, Vol 17, Iss 1, Pp 108-109 (2022)
Neural Regeneration Research
Neural Regeneration Research
Publikováno v:
Neurobiology of Aging. 62:105-119
There is a real need for new interventions for Alzheimer's disease (AD). Hyperbaric oxygen therapy (HBOT), the medical administration of 100% oxygen at conditions greater than 1 atmosphere absolute, has been used successfully to treat several neurolo
Autor:
Beka Solomon
Publikováno v:
Alzheimer's & Dementia. 14
Alzheimer’s disease (AD) is an intricate disease involving many related and interdependent pathologies that manifest simultaneously, leading to multisystemic failure, cognitive impairment, and death. As of yet, no available treatment can halt the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fc21c09db7ed201033e422c35e89c9b
https://doi.org/10.1016/b978-0-12-803690-7.00011-9
https://doi.org/10.1016/b978-0-12-803690-7.00011-9
Publikováno v:
Journal of Alzheimer's disease : JAD. 50(1)
Alzheimer’s disease (AD), the prevalent dementia in the elderly, involves many related and interdependent pathologies that manifests simultaneously, eventually leading to cognitive impairment and death. No treatment is currently available; however,
Autor:
Beka Solomon
Publikováno v:
The Scientific World Journal, Vol 9, Pp 909-919 (2009)
The Scientific World Journal
The Scientific World Journal
Naturally occurring antibodies against amyloid-β peptides have been found in human cerebrospinal fluid and in the plasma of healthy individuals, but were significantly lower in Alzheimer's disease (AD) patients, suggesting that AD may be an immunode
Autor:
Beka Solomon
Publikováno v:
Drug Discovery Today: Therapeutic Strategies. 5:185-189
After decades of arduous work, considerable progress has been made in developing a new generation of treatments that may ease symptoms of Alzheimer’s disease and might even stop its progression. Several compounds are in mid- and late-stage clinical
Autor:
Beka Solomon
Publikováno v:
Rejuvenation Research. 11:349-357
The pathology of Alzheimer's disease is characterized primarily by extracellular plaques and intracellular neurofibrillary tangles. Plaques are composed mainly of the amyloid-beta peptide, whereas tangles are derived from the cytoskeletal protein tau
Publikováno v:
Neurodegenerative Diseases. 4:392-402
Background/Objectives: Active and passive immunization methodologies against amyloid-β (Aβ) are employed to clear and reduce cerebral Aβtowards treatment of Alzheimer’s disease (AD) patients. The therapeutic potential of these antibodies in AD p